Company news

EMvision Medical Devices Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Emu Regional Benefits CRCP Progress Payment Received

November 17, 2026

Bell Potter Healthcare Conference Presentation

November 16, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 25, 2026

Notice of Annual General Meeting/Proxy Form

October 22, 2026

Mayo Clinic emu Early Clinical Experience Presentation

October 18, 2026

Date of AGM & Closing Date of Director Nominations

September 28, 2026

$4.3m Non-Dilutive R&D Tax Rebate Received

September 27, 2026

First Responder Successfully Trialled with MSU

September 15, 2026

Notification regarding unquoted securities - EMV

September 11, 2026

emu Regional Benefits Study Advancing

September 2, 2026

emu Pivotal Trial Recruitment Surpasses 200 Patients

August 30, 2026

Appendix 4E & Annual Report to 30 June 2026

August 23, 2026

FY26 Results Presentation

August 23, 2026

Appendix 4G & Corporate Governance Statement

August 23, 2026

Change of Registered Office Address

August 23, 2026

Aeromedical Study De-Risks Rural & Remote Stroke Use Cases

May 26, 2026

EMVision to Receive $1.17M IGP Grant Instalment

May 24, 2026

emu Pivotal Trial Expansion Adds Acute Ischaemia Detection

May 10, 2026

$3.8m R&D Rebate Received & Overseas Finding Approved

March 15, 2026

Update - S&P DJI March 2026 Rebalance of the All Ordinaries

March 10, 2026

S&P DJI Announces March 2026 Quarterly Rebalance

March 6, 2026

EMVision Medical Devices to Present at Australia Investor Day February 26th

February 24, 2026

Half Yearly Report and Accounts

February 22, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 27, 2026

Strong emu Clinical Trial & Program Progress

January 26, 2026

First Responder Aeromedical Study Commences

November 26, 2025

Oversubscribed SPP Raises $2.0M

October 31, 2025

Oversubscribed SPP To Close Early

October 21, 2025

$3m CRC-P Grant Executed & First Payment Received

October 13, 2025

SPP Offer Document & Option Prospectus

September 28, 2025

Pre-Hospital MSU Study Commences with First Responder Device

September 23, 2025

Firm Commitments for $12.0M Placement & Launch of SPP

September 16, 2025

Trading Halt

September 15, 2025

Appendix 4E & Annual Report to 30 June 2025

August 27, 2025

UCLA Health Activation & Continuous Innovation Study Update

August 25, 2025

EMVision Awarded $3m Grant For Regional Benefits Study

August 14, 2025

First Responder Program Advanced & Grant Milestone Achieved

July 28, 2025

Key Developments in Pivotal Trial & Innovation Study

July 1, 2025

EMVision Awarded $5m Non-Dilutive Government Grant

June 15, 2025

Additional Pivotal Trial Site Activations

June 2, 2025

Enhanced Algorithm Performance From Continuous Innovation

May 20, 2025

Activation of Second US Pivotal Trial Site, Mayo Clinic

April 27, 2025

Emu Pivotal Validation Trial Commences

March 26, 2025

First Responder Scanner in Successful Aeromedical Testing

March 18, 2025

S&P DJI Announces March 2025 Quarterly Rebalance

March 7, 2025

EMVision Releases its FY25 Half Yearly Report

February 27, 2025

US Ethics Approval Received for Pivotal Validation Trial

February 11, 2025

EMVision Receives $2.12m R&D Tax Rebate

January 19, 2025

Algorithms Deliver Excellent Results In EMView Study

November 11, 2024

EMV Prepares for Trial Following Positive FDA Engagement

October 28, 2024

Older news releases →

Decks

The 5 newest of 23 decks. Every deck is listed under its year.